CLBT Earnings

CLBT reported its earnings on 2026-05-14, showcasing a revenue of 128.30M against an estimate of 127.16M, resulting in a 0.9% surprise. The EPS was 0.06, surpassing the expected 0.08 by -25%. The stock experienced a 8.43% price change on the earnings day and a 11.24% change over the next five days, reflecting market reactions to the results.

Following CLBT's earnings announcement on 2026-05-14, the stock price moved by 8.43% on the day of the release. Over the subsequent five days, it saw a 11.24% change. Historically, CLBT's stock price tends to shift by an average of -1.25% in the 10 days leading up to earnings and 2.7% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate CLBT's annual revenue to reach 131.33M, while the EPS is projected at 0.12. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CLBT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CLBT's stock price typically moves by -1.25% in the 10 days before its earnings and 2.7% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.12 and revenue of 131.33M.

Cellebrite's earnings call shows strong financial performance with a 21% ARR growth and a 29% increase in adjusted EBITDA. The company has a solid cash position and geographic ARR growth. Despite some uncertainties in AI adoption and flat net new ARR, management remains optimistic about future growth and product adoption. The Q&A session reveals confidence in overcoming competitive threats and leveraging new products, contributing to a positive outlook. With a market cap of $2.43 billion, the stock is likely to experience a positive movement (2% to 8%) in the next two weeks.